| SNP ID |
Visualize variation |
Clinical significance |
Consequence |
| rs137852602 |
G>T |
Pathogenic |
Non coding transcript variant, intron variant, coding sequence variant, stop gained |
| rs372826934 |
G>A |
Pathogenic, conflicting-interpretations-of-pathogenicity |
Splice donor variant |
| rs567218474 |
C>T |
Pathogenic |
Non coding transcript variant, stop gained, coding sequence variant |
| rs771073292 |
G>A |
Pathogenic |
Splice donor variant, genic downstream transcript variant |
| rs778982759 |
->C |
Pathogenic |
Coding sequence variant, non coding transcript variant, intron variant, frameshift variant |
| rs863223293 |
G>A |
Pathogenic |
Coding sequence variant, non coding transcript variant, stop gained, intron variant |
| rs901844850 |
C>G,T |
Pathogenic |
Coding sequence variant, missense variant, non coding transcript variant, stop gained, intron variant |
| rs1064794659 |
C>- |
Likely-pathogenic |
Intron variant, frameshift variant, non coding transcript variant, coding sequence variant |
| rs1555507411 |
CTGGGCCCTGTCTCAGGCCCCCAGGCTTTCCCCAAACTGGTGCGGATCCTCACGGCCTTTTCCTCCCTGCAGCATCTGGAG>- |
Pathogenic |
Splice donor variant, non coding transcript variant, coding sequence variant |
| rs1596616722 |
->T |
Likely-pathogenic |
Splice donor variant, genic downstream transcript variant |
|
|
UniProt ID
Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
|
P33076 |
| Protein name |
MHC class II transactivator (CIITA) (EC 2.3.1.-) (EC 2.7.11.1) |
| Protein function |
Essential for transcriptional activity of the HLA class II promoter; activation is via the proximal promoter (PubMed:16600381, PubMed:17493635, PubMed:7749984, PubMed:8402893). Does not bind DNA (PubMed:16600381, PubMed:17493635, PubMed:7749984, |
| Family and domains |
Pfam
| Accession |
ID |
Position in sequence |
Description |
Type |
| PF05729 |
NACHT |
414 → 585 |
NACHT domain |
Domain |
| PF13516 |
LRR_6 |
984 → 1008 |
Leucine Rich repeat |
Repeat |
| PF13516 |
LRR_6 |
1013 → 1036 |
Leucine Rich repeat |
Repeat |
|
| Sequence |
MRCLAPRPAGSYLSEPQGSSQCATMELGPLEGGYLELLNSDADPLCLYHFYDQMDLAGEE EIELYSEPDTDTINCDQFSRLLCDMEGDEETREAYANIAELDQYVFQDSQLEGLSKDIFK HIGPDEVIGESMEMPAEVGQKSQKRPFPEELPADLKHWKPAEPPTVVTGSLLVRPVSDCS TLPCLPLPALFNQEPASGQMRLEKTDQIPMPFSSSSLSCLNLPEGPIQFVPTISTLPHGL WQISEAGTGVSSIFIYHGEVPQASQVPPPSGFTVHGLPTSPDRPGSTSPFAPSATDLPSM PEPALTSRANMTEHKTSPTQCPAAGEVSNKLPKWPEPVEQFYRSLQDTYGAEPAGPDGIL VEVDLVQARLERSSSKSLERELATPDWAERQLAQGGLAEVLLAAKEHRRPRETRVIAVLG KAGQGKSYWAGAVSRAWACGRLPQYDFVFSVPCHCLNRPGDAYGLQDLLFSLGPQPLVAA DEVFSHILKRPDRVLLILDGFEELEAQDGFLHSTCGPAPAEPCSLRGLLAGLFQKKLLRG CTLLLTARPRGRLVQSLSKADALFELSGFSMEQAQAYVMRYFESSGMTEHQDRALTLLRD RPLLLSHSHSPTLCRAVCQLSEALLELGEDAKLPSTLTGLYVGLLGRAALDSPPGALAEL AKLAWELGRRHQSTLQEDQFPSADVRTWAMAKGLVQHPPRAAESELAFPSFLLQCFLGAL WLALSGEIKDKELPQYLALTPRKKRPYDNWLEGVPRFLAGLIFQPPARCLGALLGPSAAA SVDRKQKVLARYLKRLQPGTLRARQLLELLHCAHEAEEAGIWQHVVQELPGRLSFLGTRL TPPDAHVLGKALEAAGQDFSLDLRSTGICPSGLGSLVGLSCVTRFRAALSDTVALWESLQ QHGETKLLQAAEEKFTIEPFKAKSLKDVEDLGKLVQTQRTRSSSEDTAGELPAVRDLKKL EFALGPVSGPQAFPKLVRILTAFSSLQHLDLDALSENKIGDEGVSQLSATFPQLKSLETL NLSQNNITDLGAYKLAEALPSLAASLLRLSLYNNCICDVGAESLARVLPDMVSLRVMDVQ YNKFTAAGAQQLAASLRRCPHVETLAMWTPTIPFSVQEHLQQQDSRISLR
|
|
| Sequence length |
1130 |
| Interactions |
View interactions |
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| MHC class II deficiency |
Likely pathogenic; Pathogenic |
rs2144414230, rs373613022, rs2144645392, rs2145059680, rs367628451, rs2144580551, rs2144701260, rs2144718631, rs2144728494, rs1306793050, rs2145173097, rs2039198631, rs778982759, rs2144743127, rs2144769768, rs777089127, rs2144710452, rs2144800871, rs2144745003, rs2144723164, rs2144614170, rs2144582937, rs748505119, rs2144743381, rs2144711765, rs2544475779, rs1209026051, rs2544514798, rs2544415250, rs2544469716, rs751733167, rs1371331693, rs1567415157, rs2544391908, rs2544432408, rs2544477641, rs2544497246, rs2544486476, rs2544490239, rs863223293, rs2544498925, rs2544478713, rs2544401055, rs2544492635, rs2544485110, rs2544468802, rs2544489480, rs139227684, rs2544499425, rs2544345786, rs2544486450, rs2040082093, rs2544468139, rs2544499041, rs2544475284, rs2544495876, rs2544491788, rs771994666, rs1450843506, rs2544496939, rs1064794659, rs372826934, rs901844850, rs567218474, rs1596513253, rs2039309312, rs2038865240, rs2039181631, rs2039957389 View all (54 more) |
RCV001379544 RCV001379491 RCV001379510 RCV001378847 RCV001390888 RCV001390506 RCV001385360 RCV001385767 RCV001386216 RCV001919931 RCV001943314 RCV001904807 RCV001999747 RCV001960612 RCV001921092 RCV002019262 RCV001963051 RCV001963060 RCV001939482 RCV001946582 RCV001972782 RCV001956226 RCV001992300 RCV001982956 RCV001935827 RCV002615300 RCV002593156 RCV002716179 RCV002740213 RCV002810229 RCV002842596 RCV002862035 RCV002894160 RCV002858358 RCV002908989 RCV003009364 RCV003019424 RCV003042644 RCV003066139 RCV003522919 RCV003524027 RCV003523874 RCV003524086 RCV003524161 RCV003524235 RCV003523695 RCV003523739 RCV003524549 RCV003524785 RCV003524454 RCV003522731 RCV003636914 RCV003636970 RCV003637288 RCV003637821 RCV003637975 RCV003635584 RCV003635626 RCV003636832 RCV003637621 RCV003822496 RCV002525849 RCV000778455 RCV000634006 RCV000822644 RCV000821315 RCV000825516 RCV001049273 RCV001212884 RCV001205159 RCV001204286 |
| MHC class II deficiency 1 |
Likely pathogenic; Pathogenic |
rs2144580551, rs777089127, rs137852602, rs771073292, rs863223293, rs1555507411, rs2145057679, rs573523090, rs2544432143, rs1064794659, rs372826934, rs778982759, rs1596513253 |
RCV005005928 RCV005017039 RCV004566712 RCV004566713 RCV004566714 RCV004566715 RCV004566716 RCV005631203 RCV004573487 RCV005018806 RCV004568315 RCV005630330 RCV005012382 |
| Rheumatoid arthritis |
Likely pathogenic; Pathogenic |
rs2144580551, rs777089127, rs1064794659, rs1596513253 |
RCV005005928 RCV005017039 RCV005018806 RCV005012382 |
|
| Phenotype Name |
Clinical Significance |
dbSNP ID |
RCV Accession |
| Acute myeloid leukemia |
Conflicting classifications of pathogenicity |
rs200599265 |
RCV005901312 |
| Cervical cancer |
Benign |
rs75483410, rs140103491 |
RCV005914472 RCV005893419 |
| CIITA-related disorder |
Likely benign; Uncertain significance; Conflicting classifications of pathogenicity; Benign |
rs1212936952, rs780711101, rs771046803, rs757458555, rs749939330, rs766316610, rs772620752, rs757444055, rs151317882, rs557455283, rs45621432, rs748330320, rs138376967, rs78108426, rs200599265, rs34648899, rs372749477, rs77169590, rs138250353, rs140486686, rs745753805, rs140139362, rs141202424, rs766538754, rs76686583, rs754706834, rs78666334, rs774399663, rs760410085 View all (14 more) |
RCV003953778 RCV003965835 RCV003965885 RCV003913608 RCV003973722 RCV003414527 RCV003983438 RCV003969812 RCV003922332 RCV003950081 RCV003922333 RCV003892127 RCV003910203 RCV003969892 RCV003925607 RCV003915500 RCV003953119 RCV003928058 RCV003945594 RCV003980225 RCV003935772 RCV003413555 RCV003962837 RCV003930495 RCV003950487 RCV003970380 RCV003960533 RCV003935907 RCV004754685 |
| Familial cancer of breast |
Benign; Likely benign |
rs4781024, rs754313400 |
RCV005914905 RCV005910813 |
| Gastric cancer |
Benign |
rs1167357099 |
RCV005871276 |
| Hepatocellular carcinoma |
Benign; Likely benign |
rs199476069, rs140103491 |
RCV005887816 RCV005893418 |
| Hodgkin lymphoma, susceptibility to |
Uncertain significance |
rs1007429981 |
RCV004515815 |
| Nonpapillary renal cell carcinoma |
Likely benign |
rs752111701 |
RCV005930447 |
| Ovarian serous cystadenocarcinoma |
Benign |
rs140103491 |
RCV005893420 |
|
| Disease Name |
Relationship Type |
References |
| Acro Osteolysis |
Stimulate |
35760800 |
| Addison Disease |
Associate |
24614117 |
| Adenocarcinoma of Lung |
Associate |
32616892 |
| Amyotrophic Lateral Sclerosis |
Associate |
37722062 |
| Anemia Hemolytic |
Associate |
26466379 |
| Anodontia |
Associate |
20013806 |
| Antisynthetase syndrome |
Associate |
30886734 |
| Arthritis Rheumatoid |
Associate |
17012290, 17075826, 20942939, 22461888 |
| Atherosclerosis |
Associate |
16439692 |
| Autoimmune Diseases |
Associate |
17012290, 18630461 |
| Bare lymphocyte syndrome 2 |
Associate |
25445815, 33386785, 9177217 |
| Behcet Syndrome |
Associate |
26833430 |
| Bone Diseases |
Associate |
23133532 |
| Bone Diseases |
Stimulate |
35760800 |
| Breast Neoplasms |
Associate |
22563434, 22942358, 26126114 |
| Carcinoma Renal Cell |
Associate |
21944129, 35739510 |
| Celiac Disease |
Associate |
20190752, 28934294 |
| Chlamydia Infections |
Associate |
10377188 |
| Colorectal Neoplasms |
Associate |
20013806, 37565053 |
| COVID 19 |
Associate |
40163554 |
| Crohn Disease |
Stimulate |
37818353 |
| Death |
Stimulate |
21944129 |
| Diabetes Mellitus Type 2 |
Associate |
22064865 |
| Eosinophilic Esophagitis |
Associate |
21281807 |
| Epstein Barr Virus Infections |
Inhibit |
25631773, 32002294 |
| Fractures Bone |
Associate |
23133532 |
| Genetic Diseases Inborn |
Associate |
12498778 |
| Hip Fractures |
Associate |
23133532 |
| Hodgkin Disease |
Associate |
21368758, 23251452 |
| Immunoglobulin G4 Related Disease |
Associate |
21989738 |
| Infections |
Associate |
23009575 |
| Inflammation |
Associate |
21944129, 22461888, 23133532 |
| Leukemia |
Associate |
14563641 |
| Leukemia Lymphocytic Chronic B Cell |
Associate |
19245431 |
| Leukemia Lymphoma Adult T Cell |
Associate |
26792751 |
| Leukemia Myelogenous Chronic BCR ABL Positive |
Inhibit |
27793879 |
| Leukemia Myeloid Acute |
Associate |
23251452 |
| Lupus Erythematosus Systemic |
Associate |
15897313, 21614020, 30674474 |
| Lymphoma |
Associate |
14563641 |
| Lymphoma B Cell |
Associate |
21368758, 23251452, 26135560, 26549456, 26599546, 31292115, 40030008 |
| Lymphoma Follicular |
Associate |
36575003 |
| Lymphoma Large B Cell Diffuse |
Associate |
19081173, 23789844, 28479318 |
| Lymphoma Large B Cell Diffuse |
Inhibit |
32002294 |
| Malocclusion Angle Class II |
Associate |
12498778, 16848795, 29527204, 37674579 |
| Melanoma |
Associate |
16312044, 17304627, 21903207, 23328677 |
| Melanoma |
Inhibit |
19862823 |
| Metabolic Diseases |
Associate |
22064865 |
| Metabolic Syndrome |
Associate |
17183695 |
| Mouth Diseases |
Associate |
37150829 |
| Multiple Myeloma |
Associate |
10542275, 17229644, 17300840 |
| Multiple Myeloma |
Stimulate |
35760800 |
| Multiple Sclerosis |
Associate |
17012290, 20211854, 20942939, 21614020, 23009575, 25992516, 26203907, 30970129, 34877984, 36282535 |
| Muscular Dystrophy Duchenne |
Associate |
23133532 |
| Myocardial Infarction |
Associate |
17012290, 17183695, 20942939 |
| Myositis Inclusion Body |
Associate |
30886734 |
| Nasopharyngeal Carcinoma |
Associate |
31922974 |
| Neoplasms |
Associate |
14970863, 21368758, 22064865, 25748235, 26229090, 32649887, 32859265, 36040405 |
| Neoplasms |
Inhibit |
22563434 |
| Neuroblastoma |
Associate |
12107114 |
| Osteoporosis |
Associate |
23133532 |
| Osteoporotic Fractures |
Associate |
23133532 |
| Pancreatic Neoplasms |
Associate |
37923686 |
| Prostatic Neoplasms |
Associate |
20053773 |
| Rhabdomyosarcoma |
Inhibit |
21989738 |
| Severe Combined Immunodeficiency |
Associate |
14678199, 15897313 |
| Small Cell Lung Carcinoma |
Associate |
12107114 |
| Stomach Neoplasms |
Associate |
32901107 |
| Testicular Germ Cell Tumor |
Associate |
25748235 |
| Thymoma |
Associate |
10886240 |
| Urinary Bladder Neoplasms |
Associate |
34404901 |
|